We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Health and industry experts attend workshop on how to give patients better access to transformative new medicines and medical technologies.
Assesses the practicality of recommendations from the Accelerated Access Review interim report.
Getting new drugs and medtech to patients faster: find out what was said.
Recommendations to build on achievements of Early Access to Medicines Scheme and improve adoption of innovative medicines across the NHS.
Rob Webster, Chief Executive of NHS Confederation, sets out his vision for a successful review.
Sir Hugh Taylor explains how your feedback has helped shape the 5 propositions in the Accelerated Access Review’s (AAR's) interim report.
Dr Stuart Dollow explains why a National Innovation Partnership is crucial to ensuring the uptake of innovation across the NHS.
Sir Hugh Taylor looks at some of the barriers that people have talked about in the Accelerated Access Review's (AAR's) engagement exercise.
Help us to speed up access to innovative drugs, devices and diagnostics for NHS patients.
The second phase of engagement kicks off with Accelerated Access Review’s (AAR) interim report from independent Chair, Sir Hugh Taylor.
Outlines the main themes in stakeholders' feedback to the Accelerated Access Review interim report.
Sir Hugh Taylor writes on the work of the Accelerated Access Review to improve access to innovative healthcare for NHS patients.
The Accelerated Access Review (AAR) has paused its online engagement to analyse the feedback received and prepare its interim report.
Review is examining pathways for pharmaceuticals, medical technology and digital healthcare across four big interconnecting themes.
Richard Stubbs, Commercial Director of Yorkshire and Humber Academic Health Science Network (AHSN), on assisting NHS front-line innovation.
Join our conversation and share your views on how to speed up access to innovative drugs, devices and diagnostics for NHS patients.
Sir Hugh Taylor talks about the need for commitment and collaboration to make sure the Accelerated Access Review proposals become reality.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.